Cargando…
RBM38 is negatively regulated by miR-320b and enhances Adriamycin resistance in breast cancer cells
Breast cancer (BC) is a common type of malignant tumor that is frequently accompanied by drug resistance, which is a significant challenge in the treatment of BC. Adriamycin (ADM) is a commonly used drug for the treatment of BC. The aim of the present study was to demonstrate the association between...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
D.A. Spandidos
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8630814/ https://www.ncbi.nlm.nih.gov/pubmed/34868364 http://dx.doi.org/10.3892/ol.2021.13145 |